# Use of ReDS Technology in Patients With Acute Heart Failure

Study · id `cardio:ct-nct04305717` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04305717](<https://clinicaltrials.gov/study/NCT04305717>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04305717

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.

## Technical summary

Registry record NCT04305717. Randomized; double masking; primary purpose treatment. Start 2020-08-14 (actual); primary completion 2021-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 240 participants (planned count; ClinicalTrials.gov record NCT04305717, source copy `cardio:ctgov-nct04305717-2021-02-21`, retrieved 2026-10-26)
- Started: 2020-08-14 (actual) (ClinicalTrials.gov record NCT04305717, source copy `cardio:ctgov-nct04305717-2021-02-21`, retrieved 2026-10-26)
- Primary completion: 2021-12 (anticipated) (ClinicalTrials.gov record NCT04305717, source copy `cardio:ctgov-nct04305717-2021-02-21`, retrieved 2026-10-26)
- Completion: 2021-12 (anticipated) (ClinicalTrials.gov record NCT04305717, source copy `cardio:ctgov-nct04305717-2021-02-21`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04305717, source copy `cardio:ctgov-nct04305717-2021-02-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04305717-2021-02-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Use of ReDS Technology in Patients With Acute Heart Failure
- Condition: Heart Failure
- Condition: Lung Congestion
- Intervention (Device): ReDS-guided strategy
- Lead sponsor: Icahn School of Medicine at Mount Sinai
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Icahn School of Medicine at Mount Sinai (`cardio:org-icahn-school-of-medicine-at-mount-sinai`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Remote Dielectric Sensing Before and After Discharge in Patients With ADHF: The ReDS-SAFE HF Trial (`cardio:pubmed-38430084`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6e281282fac4df83cc101254d1a1fbc7aa76aca54a4e2b0295c62842f2853aa0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
